Your session is about to expire
← Back to Search
Bupropion for Smoking Relapse
Study Summary
This trial will enroll pregnant women who recently quit smoking and want to stay abstinent. They will be given either a placebo or extended-release bupropion, and the effects will be monitored through questionnaires and biological sample analysis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My newborn is at high risk for seizures.I have a condition or take medication that may not mix well with bupropion.I am currently taking antidepressant medication.My health condition is stable.I am currently using aids to help me stop smoking.I have a family history of seizures.I have taken medications that could increase my risk of seizures.I am between 18 and 40 years old.
- Group 1: Placebo
- Group 2: Bupropion
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
For what medical issues is Bupropion Extended Release Oral Tablet generally recommended?
"Bupropion Extended Release Oral Tablet has been used, with varying degrees of success, to address seasonal affective disorder as well as aid in smoking cessation."
How many individuals are engaging with this experiment?
"Affirmative. According to information hosted on clinicaltrials.gov, this medical trial is presently recruiting participants; it was initially posted on January 1st 2020 and revised lastly on July 12th 2022. Specifically, the study requires 200 patients from a single location."
Is there precedent for the use of Bupropion Extended Release Oral Tablet in prior clinical experiments?
"Currently, there are 31 investigations ongoing for Bupropion Extended Release Oral Tablet with 10 of them in their final stage. Most trials are taking place at New Haven (CT), yet 283 other sites have been enlisted to run the experiments."
Is it possible for me to be a part of this research endeavor?
"This clinical trial is accepting 200 participants who have relapsed on smoking postpartum. The age range of candidates should be between 18 and 40, with a lifetime history of 100 cigarettes smoked being mandatory. Additionally, an intention to remain abstinent after delivery must score at least 7/10 on the Likert-type scale; uncomplicated delivery that was full term (37+ weeks) is also necessary for entry into this study. Prospective applicants must deny any plans to become pregnant again during this trial's duration."
How does Bupropion Extended Release Oral Tablet impact patient health over time?
"This treatment has already been approved for medical use, so it earned a safety rating of 3."
Are elderly people being accepted for the experiment?
"For this trial, the minimum age requirement is 18 years while the maximum is 40."
Are there any vacancies available for participants of this clinical trial?
"Clinicaltrials.gov confirms that this clinical trial is actively seeking out participants; the listing was first made available on January 1st 2020 and has been revised as recently as July 12th 2022."
Share this study with friends
Copy Link
Messenger